Terminated NA INTERVENTIONAL 2-arm NCT03111758

Flow Augmentation Study in Postthrombotic Patients

Flow Augmentation With Geko Device in Patients With Postthrombotic Syndrome a Prospective Randomised Cross-Over Trial

Sponsor: Maastricht University Medical Center

Updated 8 times since 2017 Last updated: Feb 16, 2022 Started: Apr 3, 2017 Primary completion: Aug 5, 2021 Completion: Aug 5, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Reaching total sample size was not feasible within the anticipated time frame.

Other terminated trials from Maastricht University Medical Center

See all terminations from Maastricht University Medical Center

Listed as NCT03111758, this NA trial focuses on Postthrombotic Syndrome and remains terminated or withdrawn. Sponsored by Maastricht University Medical Center, it has been updated 8 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Apr 2022 — Jul 2024 [monthly]

Terminated NA

Status: Unknown Status → Terminated
Jan 2021 — Apr 2022 [monthly]

Unknown Status NA
May 2019 — Jan 2021 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status

▶ Show 3 earlier versions

Jun 2018 — May 2019 [monthly]

Recruiting NA
Jul 2017 — Jun 2018 [monthly]

Recruiting NA
May 2017 — Jul 2017 [monthly]

Recruiting NA

First recorded

Apr 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Maastricht University Medical Center

Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands